scispace - formally typeset
R

Robert A. Screaton

Researcher at University of Toronto

Publications -  57
Citations -  10935

Robert A. Screaton is an academic researcher from University of Toronto. The author has contributed to research in topics: CREB & CRTC2. The author has an hindex of 31, co-authored 53 publications receiving 9968 citations. Previous affiliations of Robert A. Screaton include Sunnybrook Research Institute & Salk Institute for Biological Studies.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism

TL;DR: It is shown that hormonal and energy-sensing pathways converge on the coactivator TORC2 (transducer of regulated CREB activity 2) to modulate glucose output and compounds that enhanceTORC2 phosphorylation may offer therapeutic benefits in this setting.
Journal ArticleDOI

The CREB coactivator TORC2 functions as a calcium- and cAMP-sensitive coincidence detector.

TL;DR: A signaling module that mediates the synergistic effects of these pathways on cellular gene expression by stimulating the dephosphorylation and nuclear entry of TORC2, a CREB coactivator, consists of the calcium-regulated phosphatase calcineurin and the Ser/Thr kinase SIK2, both of which associate withTORC2.
Journal ArticleDOI

TORCs: transducers of regulated CREB activity.

TL;DR: A conserved family of coactivators, designated TORCs, for Transducers of Regulated CREB activity, that enhances CRE-dependent transcription via a phosphorylation-independent interaction with the bZIP DNA binding/dimerization domain of CREB is characterized.
Journal ArticleDOI

cAMP promotes pancreatic β-cell survival via CREB-mediated induction of IRS2

TL;DR: It is shown that mice deficient in the activity of CREB, caused by expression of a dominant-negative A-CREB transgene in pancreatic β-cells, develop diabetes secondary to β-cell apoptosis, a novel mechanism by which opposing pathways cooperate in promoting cell survival.